Developed to provide drug developers with a range of compatible primary and secondary packaging components to be used in every drug development application, the StarterPack™ enables manufacturers to incorporate high-quality components and commercial packaging solutions into their testing and clinical trial strategy including diagnostic research, clinical trials, and product launches. Helping to minimize time during early stages, quantities can also be ramped up once drug products are ready for commercial launch.
The StarterPack™ contains the company’s OmniFlex® stoppers alongside adaptiQ® vials from SCHOTT. The OmniFlex® stoppers are 100 percent spray coated with a proprietary, inert, no-added silicone, fluoropolymer, providing a robust barrier between drug and rubber to minimize extractables and leachables. Datwyler’s StarterPack™ also contains Datwyler’s PrimeCaps™ which are made with the highest quality alloy optimized with an Accurim straight skirt edge and present low bioburden and particulate levels. The combination of the Datwyler OmniFlex® stopper, PrimeCap™, and SCHOTT adaptiQ® glass vial, offers a comprehensive packaging solution to ensure drug efficacy, stability, and, ultimately, patient safety.
Datwyler manufactures its OmniFlex® stoppers to FirstLine® production standards. At CPhI Worldwide, representatives will be available to discuss how the company’s network of FirstLine® facilities marry best-in-class production technologies with fully integrated cleanroom environments in plant locations across the world to maximize geographical options for sourcing.